Univ.-Prof Dr. Michael Brainin

Benjamin, IJ.: Kreutz, R.; Olsen, MH.; Schutte, AE.; Lopez-Jaramillo, P.; Frieden, TR.; Sliwa, K.; Lackland, DT.; Brainin, M. (2019). Fixed-dose combination antihypertensive medications. Lancet, 394(10199): 637-638

Brainin M. (2019). Poststroke Cognitive Recovery Prediction. Stroke, 50(10): 2647

Brainin, M. (2019). Stroke epidemiology in China: which are the next steps? Lancet Neurology, 18(4): 325-326

Brainin, M.; Feigin, V.; Bath, PM.; Collantes, E.; Martins, S.; Pandian, J.; Sacco, R.; Teuschl Y. (2019). Multi-level community interventions for primary stroke prevention: A conceptual approach by the World Stroke Organization. Int J Stroke, 1747493019873706: 10.1177/1747493019873706

Diener, HC.; Sacco, RL.; Easton, JD.; Granger, CB.; Bernstein, RA., Uchiyama, S.; et al. (2019). Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source. New England Journal of Medicine, 380 (20): 1906-1917

Feigin, V.; Brainin, M. (2019). Reducing the burden of stroke: Opportunities and mechanisms. Int J Stroke, 14 (8): 10.1177/1747493019874718

Martins, S., Sacks, C.; Hacke, W.; Brainin, M.; et.al. (2019). Priorities to reduce the burden of stroke in Latin American countries. Lancet Neurology, 18(7): 674-683

Pierot, L.; Jarayaman, M.; Szikora, I.; Hirsch, J.; Baxter, B.; et al (2019). Standards of Practice in Acute Ischemic Stroke Intervention International Recommendations. Canadian Journal of Neurological Sciences, 46(3):269-274: 10.1017/cjn.2019.1

ASPIS Study Group (2018). Multidomain intervention for the prevention of cognitive decline after stroke - a pooled patient-level data analysis. Eur J Neurol., 25: 1182-1188

Brainin M. (2018). Stroke units around the world: the success story continues. Lancet, 18: 1970-1971

Brainin M. (2018). Cerebrolysin: a multi-target drug for recovery after stroke. Expert Rev Neurother, 18: 681-687

Brainin, M. (2018). Prevention of Stroke: Antihypertensives, Cholesterol-Lowering, Drugs, Antithrombotics, Anticoagulation, Carotid Surgery and Stenting. Hamdan Medical Journal, 11/1: 10.4103/2227-2437 228869

Brainin, M. (2018). Secondary Stroke Prevention offers now more choices and is critical to reduce the burden of recurrent stroke and death. Hamdan Medical Journal, 11/1: 10.4103/2227-2437228868

Brainin, M. et. al. (2018). Postitionspapier der ÖGSF. neurologisch, Supplementum: 3-15

Brainin, M.; Feigin, V.; Martins, S.; Matz, K.; Roy, J.; Sandercock, P.; Teuschl, Y.; Tuomilehto, J.; Wiseman, A. (2018). Cut stroke in half: Polypill for primary prevention in stroke. Int J Stroke, 25: 633-647

Brainin, M.; Teuschl, Y. (2018). Poststroke Neurocognitive Disorders Are Mostly Defined by Strategic Lesions. Stroke, 49: 2563-2564

Brainin, M; Teuschl, Y. (2018). Poststroke Neurocognitive Disorders Are Mostly Defined by Strategic Lesions. Stroke, 49/11: 2563-2564

GBD 2017 Disease and Injury Incidence and Prevalence Collaborators (2018). Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet, 10.1016/S0140-6736(18)32279: 1789-1858

GBD 2017 Population and Fertility Collaborators. (2018). Population and fertility by age and sex for 195 countries and territories, 1950-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet, 10.1016/S0140-6736(18)32278: 1995-2051

GBD 2017 SDG Collaborators (2018). Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories: a systematic analysis for the Global Burden of Disease Study 2017. Lancet, 10: 2091-2138